“Because the use of marijuana under AMMA ‘must be considered the equivalent of the use of any other medication under the direction of a physician,’ the exposure of [the plaintiff’s] infant to marijuana resulted from medical treatment and did not constitute neglect under A.R.S. § 8–201(25)(c).”
Under the new law, patients with insomnia and/or autism spectrum disorder are eligible to obtain medical cannabis access.
“Our current model of federal prohibition represents the utter lack of control over any aspect of marijuana or the marijuana market. The Surgeon General’s time would be better spent advocating for a legally and tightly regulated cannabis market – one in which we educate Americans about the potential harms and benefits of cannabis through evidence-based public education campaigns – rather than through fear-mongering.”
[Editor’s note: This post is excerpted from next week’s forthcoming NORML weekly media advisory. To…